yashivaidya

  Market Highlights Mixed Reality (MR) is a combination of Augmented Reality (AR) and Virtual Reality (VR), defining the polar ends of a spectrum known as virtuality spectrum or mixed reality spectrum. Augmented reality delivers digital components, whereas virtual reality enables immersive imitation of real-life settings. MR has widespread applications in different fields of healthcare, varying from treatment to training and education. It is estimated that the global mixed reality in healthcare market is expected to register a CAGR 26.3% during the forecast period of 2020 to 2027, with an estimated market value of USD 2,475 million in 2027. Numerous factors such as rapid improvements in the adoption of sensor technology, increase in the user acceptance, increased applications of MR in disease care and treatment, and increasing workload of healthcare professionals are anticipated to fuel the growth of the market. Additionally, the benefits of MR systems such as operational efficiency, i

  Market Insights Market Research Future has revealed that the global autoinjectors market is expected to witness exponential growth at a CAGR of over 25% during the forecast period of 2020 to 2027. Autoinjectors are an advancement in healthcare which dispenses a single dose of the given drug in an easy, and safe manner. Autoinjectors are commonly known for their use in epinephrine pen which is used to offer emergency care to patients suffering from anaphylactic shock. Other applications for autoinjectors in healthcare in addition to the above are expected to spur growth for the global autoinjector market. Increasing prevalence of targeted therapies for the treatment of various conditions is expected to increase market value. The growing diagnosis of diseases such as diabetes and a general increase in anaphylaxis have increased the demand for autoinjectors. Moreover, design development to increase efficiency and safety with which medicine is delivered combined with technological advanc

  Market Highlights Stethoscope Market is expected to register a CAGR 5.2% with an estimated market value of USD 520.0 million during the forecast period of 2021 to 2028. The global  stethoscope market  is currently dominated by many market players. The key players in the market are involved in new product launches and strategic partnerships to strengthen its market position. For instance, in January 2018, M3DICINE Inc, announced the launch of Stethee, the world’s first AI-enabled stethoscope system. Also, in September 2015, eKuore launched the first wireless stethoscope in Düsseldorf, Germany. Numerous factors such as increasing incidence rate of life-threatening diseases, increased spending on healthcare, and continuous research and development in the diagnostic field are anticipated to fuel the growth of the market. The technological improvements such as Bluetooth connectivity with digital wireless hearing aids is expected to fuel the market growth. Also, increasing research activit

  Market Highlights It is estimated that the global medical telemetry market is expected to register a CAGR ~13.90% during the forecast period of 2022 to 2030.  The global  medical telemetry market  is expected to witness tremendous growth owing to the information and communication technology or ICT, advancement in mobile perforation, and connectivity in the region is driving the growth of the medical telemetry market. Other factors such as the advent of various new-age facilities such as mHealth, virtual visits, and tele-ICUs. The industry players such as InTouch Health, iRobot, and Vecna Technologies have developed robots that serve as the physician's stand-in in remote clinics, which are the key factor driving the growth of the segment. However, factors such as low awareness about telemetry in the emerging region are expected to curb the growth of the market during the forecast period. Regional Analysis On a regional basis, the medical telemetry market in the Americas is predict

  Market Highlights Cardiology picture archiving and communication systems (CPACS) and cardiovascular information systems (CVIS) provide various advantage to health systems when successfully implemented. By comparing CPACS vs. CVIS, CPACS, similar to radiology PACS, mainly focuses on the storage and retrieval of cardiology-centric images. The growth of the global cardiovascular information system (CVIS) is driven by the factors such as the rising incidence of heart disease, increasing government initiatives towards the implementation of electronic health record systems,technological development, increasing demand for data-driven technologies is expected to propel the growth of this market. The global  cardiovascular information system (CVIS) market  is expected to have a market value of USD 1,560.93 million by 2027. Regional Analysis The global cardiovascular information system (CVIS) market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East

Market Insights The global cell therapy market is due to grow at a CAGR of 9.3% during the forecast period of 2022 to 2030 according to Market Research Future's latest report on the subject. Cell therapy market  has emerged as a transformative field in biotechnology due to its use for the targeting of various diseases at a cellular level. The above-average growth expected by this market will primarily be due to the rapidly advancing healthcare sector and growing breakthrough research and development activities. Cell therapy is finding a growing number of applications in healthcare and is often used in combination with gene therapy. Presently, applications of cell therapy include urinary problems, cancers, autoimmune disease, and infectious disease among several others. The growing prevalence of chronic and lifestyle diseases is an important driver for the cell therapy market.  cell therapy processing  is also being developed in regenerative medicine which carries massive potential

  Market Highlights The global  drug discovery informatics market  held a market value of USD 6.3 billion in 2030 and is projected to grow at a CAGR of 10.8% over the forecast period. Drug discovery and development is an extremely complex process requiring the generation of very large amounts of information data and. As the pharmaceutical and biotechnology industry is on the rise, information technology is supporting the drug discovery process to improve research productivity and success rates. Patent expiry of blockbuster drugs, an over-reliance on high throughput discovery strategies, and ongoing industry consolidation through mergers and acquisitions (M&A) are fueling the demand for drug discovery informatics. Few of the market growth factors include a worldwide rising focus on drug discovery, growing need to control drug discovery and development costs, rising research and development (R&D) expenditure, and increasing burden of chronic diseases. For instance, according to t

  Market Highlights The rising cases of sports-related injuries and technological advancements are some of the key factors driving the soft tissue repair market. For instance, in 2016, Colorado Therapeutics received FDA approval for its xenograft implant. The xenograft implant is designed for the surgical repair of damaged or ruptured membranes. The Global  Soft Tissue Repair Market  is expected to grow at an approximate CAGR of 7.4% during the forecast period, 2022–2030. Various other factors such as increasing awareness about orthopedic disorders and other related conditions, improvement in reimbursement policies, untapped emerging markets, and increasing healthcare expenditure are also expected to propel the growth of the market. However, the high cost of  advanced soft tissue release  equipment and a shortage of physicians in emerging markets can hamper market growth over the forecast period. Regional Analysis In 2017, it was estimated that Europe stood second in the global soft ti

  Market Highlights The emergence of 3D and 4D imaging technologies, increasing the prevalence of geriatric population and subsequent growth in the incidence of cardiac, and neurological diseases including cancer, growing government funding’s for development of medical diagnostics field are some factors that are anticipated to drive the market growth during the assessment period.  Additionally, a rise in the number of diagnostic centers and increased healthcare expenditure is likely to contribute to market growth. As per the data by the Office for National Statistics, in 2016, the gross domestic expenditure on research and development (R&D) was Euro 33.1 billion (USD 35.2 billion) in the UK. However, the high cost of equipment related to clinical validation and lack of skilled professionals may hamper the market growth during the assessment period. The global  medical imaging software market  held a market value of USD 2,899.61 million in 2022 and is projected to grow at a CAGR of

  Healthcare Predictive Analytics Market Overview The global healthcare predictive analytics market is expected to witness tremendous growth owing to the government initiatives to increase EHR adoption, growing venture capital investments, growing pressure to curb healthcare spending and improve patient outcomes. Other key factors such as rising healthcare costs; curb fraudulent claims, optimize provider networks, operational costs; increasing competition, the growing need to increase memberships are compelling healthcare payers to adopt analytics solutions. It is estimated that the global  healthcare predictive analytics market  is expected to register a CAGR ~29.50% during the forecast period of 2022–2030. Healthcare Predictive Analytics Market Regional Analysis On the regional basis, the healthcare predictive analytics market in the Americas is predicted to dominate the market during the forecast period. The North American region holds substantial share in the global market. Healthc

Market Analysis Various factors are propelling the surgical drills market growth. Some of these factors according to the Market Research Future report, include rising medical tourism, growing elderly population, changing lifestyle, changing eating habits of consumers, excessive alcohol consumption, rising number of dental and orthopedic surgeries, and rising awareness about dental hygiene. Additional factors pushing market growth include high disposable income, increasing prevalence of chronic diseases which need surgical procedures, upgrading of healthcare equipment and infrastructure, and constant development in surgical drill technology. The Global  Surgical Drills Market  is predicted to grow at a 4.93% CAGR over the forecast period (2020-2027), states the latest Market Research Future (MRFR) report. A surgical drill, simply put, is a device used for boring holes in bone for attaching screws, plates, or surgical pins or reshaping teeth and removing decay for a filling. These precis

  Market Highlights: Particle Therapy are used for the treatment of various type of cancer such as prostate cancer, lung cancer, pediatric cancer, head and neck cancer, breast cancer, and others by using most advanced areas of external beam radiation therapy. The increasing number of cancers affected population, increasing adoption of particle therapy, and rising  particle therapy market  centres across the globe are the major factors driving the growth of the global particle therapy market. Additionally, increasing R&D spending and aggressive strategies adopted by the top players are fueling the growth of the market during forecast period. For instance, according to report published by Particle Therapy Co-Operative Group, in 2016, till 2014 around 1802 patients were treated with particle therapy. Whereas, in United States, around 78,613 cancer patients were treated with particle therapy till 2016.The high costs associated with establishments of centers and lack of reimbursement po

  Overview The Global Renal Denervation Market is expected to rise at a solid CAGR of 40.4% over the forecast period, according to a new research report from Market Research Future (MRFR). The market’s value is expected to rise from USD 200 million in 2020 to USD 2,850 million in 2027. The global  renal denervation market  is expected to be driven mainly by the rising prevalence of hypertension around the world. Hypertension has been one of the main beneficiaries of the modern lifestyles and dietary patterns and has grown in prevalence steadily over the last decade and more. This trend is likely to be followed over the coming years as more countries experience the negative effects of rapid urbanization and wide-scale industrialization on the health of the population. Hypertension is likely to be one of the diseases on the rise in developing countries that are pursuing large-scale urbanization and industrialization, leading to favorable growth prospects for the renal denervation market

  Market Overview Nuclear Medicine is a branch of medicine which uses radioactive substances in small amounts for diagnosis and treatment of various diseases. Nuclear medicine can be used for the treatment of various conditions including blood disorder, and some cancers and use vastly different imaging technologies than those used in traditional imaging as they show physiological function of the particular system making it a more targeted method of imaging. Market Research Future's report on the global  nuclear medicine supplies  market divulges a number of vital figures and facts about the market. Nuclear Medicine Market is projected to grow at a CAGR of 13% over the review period. With the rapid expansion of advanced medical technologies, the market is expected to grow at a consistent upward trend to approximate market value of USD 13 Bn by the end of 2027. Nuclear medicine market offers precise diagnostic abilities and is useful in the early detection of cancer as well as other

  Market Highlights The increasing prevalence of Addison’s disease and rising research & development activities to produce new products for diagnosing and treating diseases is expected to drive market growth over the forecast period. According to a report published by the National Center for Biotechnology Information in June 2017, the incidence rate of Addison’s disease is 0.6 per 100,000 of the population per year. Despite the drivers, difficulty in diagnosis in early stages and lack of knowledge can restrain the market growth over the assessment period. The Global  Addison’s Disease Market  is anticipated to hold a market value of USD 168 million in the year 2027 and is expected to grow at a CAGR of 10.4% during the forecast period. Addison’s disease occurs when the body starts producing inadequate amounts of certain hormones produced by adrenal glands. The glands start to produce too less cortisol and aldosterone as well.  Addison’s disease is a rare disorder, and only 1 in 100,